drugset / Trial / NCT01902108

Added Value of Local Clonidine for Spine Postoperative Pain Control, in Addition to Bupivacaine

NCT01902108

Phase 4 Completed 225 enrolled St Joseph University, Beirut, Lebanon
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this prospective randomized double-blind study is to evaluate the added analgesic value of clonidine to the conventional local bupivacaine wound infiltration in posterior spine surgery.

Timeline

Start
2013-01
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 150 ug Other
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.